Globe Newswire
In the third quarter of 2026, EfTEN United Property Fund earned a net profit of 68 thousand euros (Q3 2025: 426 thousand euros). The decrease in profit is mainly related to the fund's investment in the development company Invego Uus-Järveküla OÜ, where the majority of the sales of completed terraced houses, and the resulting profit, fell in the previous year. Despite the decrease in profit, EfTEN United Property Fund received record income from its investments, which... (continue reading...)
COMMENTARY FROM MANAGEMENT
Merko Ehitus generated revenue of EUR 118 million in the third quarter of 2026 and EUR 268 million in the nine months of the year. Net profit amounted to EUR 12.6 million for the third quarter and EUR 25.4 million for the nine months of 2026.
According to the management of Merko Ehitus, real estate development and construction services both contributed equally to group third-quarter results. During the quarter completed and handed over 118... (continue reading...)
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
- Ongoing negotiations with different parties towards securing a partnership or financing for the development of varoglutamstat in kidney disease
- Agreement with partner Simcere Pharmaceutical Group Ltd. to regain development and commercial rights for lead asset varoglutamstat in Greater China, consolidating global rights and supporting Vivoryon’s strategic focus on kidney disease
- New... (continue reading...)
Senior M&A advisor brings more than 16 years of experience and has led financial due diligence engagements on more than 150 transactions worldwide
PARIS, Nov. 05, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Aurélien Louis as a Senior Managing Director in the Transactions practice within the firm’s Corporate Finance segment. Mr. Louis, who is based in Paris, brings more than 16 years of mergers and acquisitions (“M&A”)... (continue reading...)
Siemens Healthineers announced today it has initiated the carve-out process for its in vitro diagnostics business
Tarrytown, New York, USA, Nov. 05, 2026 (GLOBE NEWSWIRE) --
- The company is preparing its Diagnostics business to become a standalone organization
- The name, Olyrian Diagnostics, will be rolled out in stages
- Olyrian will advance diagnostics along the care continuum, from patient draw to population health
Siemens Healthineers announced today it has initiated... (continue reading...)
More Globe Newswire
View Older Stories-
Syensqo third quarter 2026 results
-
IMCD reports EBITA of EUR 425 million (+8%) in the first nine months of 2026
-
ForFarmers N.V.: Trading update Q3 2026
-
ArcelorMittal reports third quarter 2026 results
-
Start of Day Message
-
2026 III quarter and 9 months consolidated interim report (unaudited)
-
IBA signs contract with the Government of Assam for India’s First State-run Proton Therapy Center
-
WISeQey Advances PKI Modernization as Recent Cyberattacks Highlight the Need to Limit Identity and Credential Risks
-
Molecular Partners to Present on DLL3-Targeting Radio-DARPin MP0712 at 2026 SNMMI Theranostics Conference and NACLC 2026
-
NORBIT - Invitation to presentation of NORBIT's third quarter results, 12 November 2026
-
Zelluna ASA: Third Quarter 2026 results
-
Interim Report for Q3 2026
-
VGP NV: Trading Update
-
Q3 2026 Update: Tecan reports acceleration of sales growth in Q3 and raises full-year 2026 outlook
-
Lumo Homes Plc: Lumo Homes plc’s Interim Report 1 January–30 September 2026
-
Bekaert to acquire Dextra, a leading provider of sustainable construction reinforcement solutions
-
Interim Report Q3 2026: Successful product launches leading to 2% organic revenue growth and margin expansion
-
Wood Mackenzie: One in five refineries at closure risk as global oil demand peaks in 2032
-
TTAN Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against ServiceTitan, Inc.
-
Financial institutions accelerate transition to multi-agent AI in drive for bottom-line value
-
DOX Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Amdocs Limited
-
2026 Results of Annual General Meeting
-
DeFi Technologies Announces Shareholder Call to Discuss Q3 2026 Financial Results
-
Cardinal Point Wealth Management Highlights Estate Planning Considerations for Canadians with U.S. Assets
-
Fortuna Reports Results for the Third Quarter 2026
-
From Individual Upgrades to a Complete Workstation: Four Home Office Setup Ideas from Eureka Ergonomic
-
3D Systems Announces Agreements to Exchange All Outstanding 5.875% Convertible Senior Secured Notes Due 2030, Eliminating All Secured Debt
-
NEXSOLACE Presents SUPER GROOMER to Spotlight Professional Pet Grooming Talent
-
The Manufacturing Foundation Behind AiMOGA and LUXEED: How Chery’s Capabilities Support Two Global Brands
-
Physical AI Empowers Smart Mobility: LUXEED Builds a New Full-Scenario Intelligent Ecosystem
-
FlutterFlow Launches AI-Native App Builder for iOS and Android
-
Backed by Chery's Global NEV Ecosystem, LUXEED Delivers Multi-Scenario Intelligent Luxury Mobility
-
Backed by Chery's Global NEV Ecosystem, LUXEED Delivers Multi-Scenario Intelligent Luxury Mobility
-
Cloudbreak Pharma Announces Top-Line Results from its Phase 3 Study of CBT-001 in Patients with Pterygium
-
Live Oak Bancshares, Inc. Prices Depositary Share Offering
-
Beyond Meat® Reports Third Quarter 2026 Financial Results
-
Step Pharma to present data from ongoing phase 2 clinical trial of dencatistat in essential thrombocythaemia at 68th ASH Annual Meeting
-
Heartland Express, Inc. Announces Participation in Upcoming Conference
-
Use Of Ryoncil First Line After Steroids For Pediatric Acute Graft Versus Host Disease Highlighted In Key Opinion Leader Webinar
-
HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia
-
TaiMed Biologics to Present 24-Week Phase 2a Data on TMB-365/TMB-380 Maintenance Regimen at HIV Glasgow 2026
-
The Two-Year Brand Project Is Over: EducationDynamics Launches Process That Puts New Brand in Market in 90 Days
-
Ascentage Pharma to Present Data from Multiple Trials, Including an Oral Presentation of APG-5918 at ASH 2026
-
Five Star Bancorp Appoints Banking Veteran Christopher D. Myers to its Board of Directors
-
Five Star Bancorp Appoints Banking Veteran Christopher D. Myers to its Board of Directors
-
Perimenopause Gets a Seat at the Table: Pemi Launches Supper Club Series With Inaugural NYC Gathering
-
Itafos Reports Q3 2026 Financial Results and Operational Highlights
-
COMSTOCK RESOURCES, INC. REPORTS THIRD QUARTER 2026 FINANCIAL AND OPERATING RESULTS
-
DDC Enterprise Announces Proposed Public Offering of DDC SAVOR 13.5% Perpetual Preferred Series A Shares
-
Trekor Announces $164 Million of Adjusted EBITDA in Third Quarter


